SHMT2 and infantile convulsions and choreoathetosis: In addition to the tumor number and T stage, multivariate analysis and the Cox proportional hazard regression model revealed that SHMT2 expression is an independent prognostic factor for patients with iCCA, consistent with previous SHMT2 clinical reports in other solid cancers [6–8, 23].